ARTICLE | Clinical News
PVAC: Started Phase II trials
January 17, 2000 8:00 AM UTC
Corixa Corp. (CRXA), Seattle, Wash. Product: PVAC Business: Autoimmune/Inflammation Therapeutic category: Immune modulation Target: Immune system Description: Heat-killed Mycobacterium vaccae extract...